KD Pharma:
Site Relocation
Relocation from Switzerland to UK
• Plant designed and constructed in early 2000 (Pre-ATEX regulation)
• Conformity to modern UK regulation & requirements
• Concept to commissioning (Control System)
• CDMO facility requirements – adherence to flexible and scalable design requirements
• Working with Siemens against bespoke DCS requirements
• EC&I consultation and project development
• Analytical review of legacy plant and conformity reporting